Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Aug 6, 2013, during market hours
10-Q filed Aug 6, 2013, 37 days after period end · 0001104659-13-060306
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Net Income | — | — | -$21.47M | $27.03M |
| EPS Diluted | -$0.26 | -$0.35 | -$0.37 | $0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2013 · filed Aug 6, 2013 · 37 d after period end
+3.5% from the close of Aug 5, 2013 to the close of Aug 6, 2013, the first after the release.
